abstract |
The present invention is directed to compositions and methods for inhibition of APOBEC-related DNA cytosine deaminase enzymes, and to methods of using the compounds for treatment of a disease in a patient, such as an infectious disease or a cancer. The infectious disease can be a viral disease, e.g., HIV, or can be a cancer, such as a breast, bladder, cervical, head, or neck cancer, or a lung squamous cell carcinoma or lung adenocarcinoma. |